Home › NDC Lookup › RxCUI directory › RxCUI 198750

Methylcellulose 500 MG Oral Tablet — RxCUI 198750

RxNorm drug concept · Semantic clinical drug
RxCUI 198750 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 20 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198750
Official nameMethylcellulose 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped20
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Methylcellulose 500 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methylcellulose 500 MG Oral Tablet RxCUI 198750

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methylcellulose 6873
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Citrucel 92170
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylcellulose Oral Tablet 372851
    • Methylcellulose Oral Product 1162873
    • Methylcellulose Pill 1162874
    • Methylcellulose Oral Tablet [Citrucel] 368670
    • Citrucel Oral Product 1170940
    • Citrucel Pill 1170941
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methylcellulose 500 MG SCDC · 316282
  • Methylcellulose Oral Tablet SCDF · 372851
  • Methylcellulose Oral Product SCDG · 1162873
  • Methylcellulose Pill SCDG · 1162874

Brand-Name Concepts

  • Methylcellulose 500 MG Oral Tablet [Citrucel] SBD · 352178
  • Methylcellulose 500 MG [Citrucel] SBDC · 575911
  • Methylcellulose Oral Tablet [Citrucel] SBDF · 368670
  • Citrucel Oral Product SBDG · 1170940
  • Citrucel Pill SBDG · 1170941
  • Citrucel BN · 92170

📦 FDA Products & Package NDCs

14 products · 20 package NDCs
20 package NDCs map to RxCUI 198750 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00135-0199-01 180 TABLET in 1 BOTTLE (0135-0199-01) CITRUCEL Haleon US Holdings LLC 2010-02-01
00135-0199-02 100 TABLET in 1 BOTTLE (0135-0199-02) CITRUCEL Haleon US Holdings LLC 2010-02-01
00135-0199-06 2 TABLET in 1 POUCH (0135-0199-06) CITRUCEL Haleon US Holdings LLC 2010-02-01
00135-0199-07 240 TABLET in 1 BOTTLE (0135-0199-07) CITRUCEL Haleon US Holdings LLC 2010-02-01
00135-0199-08 50 POUCH in 1 CARTON (0135-0199-08) / 2 TABLET in 1 POUCH (... CITRUCEL Haleon US Holdings LLC 2010-02-01
00135-0199-09 1 BOTTLE in 1 PACKAGE (0135-0199-09) / 240 TABLET in 1 BOTT... CITRUCEL Haleon US Holdings LLC 2017-02-15
00363-1220-10 100 TABLET in 1 BOTTLE (0363-1220-10) Walgreens Fiber Therapy WALGREENS CO. 2019-05-14
11822-2221-00 100 TABLET in 1 BOTTLE (11822-2221-0) Rite Aid Fiber Therapy RITE AID CORPORATION 2019-03-12
11822-2221-02 200 TABLET in 1 BOTTLE (11822-2221-2) Rite Aid Fiber Therapy RITE AID CORPORATION 2019-03-12
41163-0288-16 100 TABLET in 1 BOTTLE (41163-288-16) Soluble Fiber United Natural Foods, Inc. dba UNFI 2018-08-24
41250-0212-10 100 TABLET in 1 BOTTLE (41250-212-10) meijer Fiber Therapy MEIJER DISTRIBUTION INC 2017-03-14
49035-0756-10 100 TABLET in 1 BOTTLE (49035-756-10) equate Fiber Therapy Wal-Mart Stores,Inc., 2017-08-30
50804-0364-16 100 TABLET in 1 BOTTLE (50804-364-16) Goodsense Fiber GoodSense 2015-12-01
51316-0122-00 100 TABLET in 1 BOTTLE (51316-122-00) CVS Fiber Therapy CVS PHARMACY 2023-09-14
63868-0166-10 100 TABLET in 1 BOTTLE (63868-166-10) CDMA Fiber Therapy CHAIN DRUG MARKETING ASSOCIATION 2019-04-19
63941-0122-10 100 TABLET in 1 BOTTLE (63941-122-10) Best Choice Fiber Therapy BEST CHOICE (VALU MERCHANDISERS COMPANY) 2019-04-19
68016-0122-10 100 TABLET in 1 BOTTLE (68016-122-10) Premier Value Fiber Therapy PHARMACY VALUE ALLIANCE, LLC 2019-04-19
68163-0122-00 100 TABLET in 1 BOTTLE (68163-122-00) DRx Choice Fiber Therapy RARITAN PHARMACEUTICALS INC 2022-07-20
72288-0122-00 100 TABLET in 1 BOTTLE (72288-122-00) AMAZON FIBER THERAPY AMAZON.COM SERVICES LLC 2025-12-01
83324-0228-01 100 TABLET in 1 BOTTLE (83324-228-01) QUALITY CHOICE Fiber Therapy CHAIN DRUG MARKETING ASSOCIATION 2024-09-20
Observed labelers: Haleon US Holdings LLC (6) · CHAIN DRUG MARKETING ASSOCIATION (2) · RITE AID CORPORATION (2) · AMAZON.COM SERVICES LLC (1) · BEST CHOICE (VALU MERCHANDISERS COMPANY) (1) · CVS PHARMACY (1) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.